White label ELPA - ClinicalTrials.eu

A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

Recruiting

2 1
Investigated diseases:
- Atrial fibrillation
A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

Recruiting

3 1 1 1
Investigated diseases:
- Cardiac failure
Investigated drugs:
Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

Recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
A Study Testing VX-407 in Patients with Autosomal Dominant Polycystic Kidney Disease Who Have Specific PKD1 Gene Changes

Recruiting

2 1 1
Investigated drugs:
- VX-407
A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Recruiting

3 1 1
Investigated diseases:
- Major depression
Investigated drugs:
- Esketamine
- Midazolam
A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Recruiting

3 1 1 1
Investigated diseases:
- Lung neoplasm malignant
- Non-small cell lung cancer
Investigated drugs:
+5
A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

Recruiting

2 1
Investigated diseases:
- Cardiomyopathy
- Hypertrophic cardiomyopathy
+3
Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer

Recruiting

4 1 1 1
Investigated diseases:
- Cholangiocarcinoma
Investigated drugs:
Comparing Remimazolam and Propofol for Deep Sedation in Patients Undergoing Endoscopic Ultrasound for Gastric and Pancreatic Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Gastric cancer
- Pancreatic carcinoma
Investigated drugs:
- Propofol
- Remimazolam
A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies